1 Min Read
Aug 2 (Reuters) - Novartis AG:
* NOVARTIS PHARMACEUTICALS CANADA SAYS HEALTH CANADA APPROVED AIMOVIG FOR PREVENTION OF MIGRAINE IN ADULTS WHO HAVE AT LEAST 4 MIGRAINE DAYS PER MONTH Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.